Prenatal Trikafta treatment of three fetuses with cystic fibrosis (CF) for an intestinal blockage called meconium ileus resulted…
Articles by Steve Bryson, PhD
The U.S. Food and Drug Administration (FDA) has expanded the approval of Trikafta for people with cystic fibrosis…
Infants with cystic fibrosis (CF) have alterations to the nasal microbiome — the community of microbes that live in…
About half of people with cystic fibrosis (CF) had breathing difficulties during sleep a year after a lung transplant,…
Treatment with Kalydeco (ivacaftor) reduces the number of Pseudomonas aeruginosa bacteria in the lungs during an acute infection, but…
Researchers discovered a molecule that may help deliver gene therapies to cells in the thick mucus environment of the…
Since its approval in 2019, treatment with Trikafta has markedly reduced the number of lung transplants among people in…
People with cystic fibrosis-related diabetes (CFRD) have lower pancreatic production of the GLP-1 receptor (GLP-1R), a protein that binds…
A more rapid decline in lung function in people with cystic fibrosis (CF) has been linked in a new…
Although parents of children with cystic fibrosis (CF) recognize the benefits of their children getting physical activity in schools,…